Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 2 (PCMTD1P2) is a pseudogene, meaning it is a DNA sequence resembling a gene but generally considered non-functional for protein coding due to inactivating mutations. Pseudogenes may have regulatory functions at the RNA level, such as acting as decoys for microRNAs or regulating the expression of protein-coding relatives through RNA-based mechanisms[1][2]. However, there is no evidence that PCMTD1P2 itself is functional in this way, and it is not recognized as a receptor, enzyme, transporter, or therapeutic target. Most databases and scientific literature classify it as a non-functional genomic element with no established role in pathology or as a drug target. It should not be regarded as a conventional molecular target.
Not applicable; not known or predicted to directly interact with drugs or function as a therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 2 (PCMTD1P2).